1.
Journal of Applied Clinical Pediatrics
; (24)2004.
Artigo
em Chinês
| WPRIM
| ID: wpr-640274
RESUMO
Juvenile idiopathic arthritis(JIA)is the most common rheumatology disease in childhood period with poor prognosis.The biological agents are newly developed drugs with features of clear therapeutic targets and fast effects.But its use in JIA is still limited,so this article focuses on the clinical use experience,timming and sideffects of the biological agents on JIA.